Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
| Class:Id | LiteratureReference:9794809 |
|---|---|
| _displayName | Tranilast directly targets NLRP3 to treat inflammasome-driven diseases |
| _timestamp | 2022-07-20 21:22:00 |
| author | [Person:9716142] Huang, Yi [Person:9794807] Jiang, Hua [Person:9615078] Chen, Yun [Person:9794813] Wang, Xiaqiong [Person:9772395] Yang, Yanqing [Person:9794819] Tao, Jinhui [Person:9794817] Deng, Xianming [Person:9794810] Liang, Gaolin [Person:9794808] Zhang, Huafeng [Person:5674644] Jiang, Wei [Person:9712477] Zhou, Rongbin |
| created | [InstanceEdit:9794814] Shamovsky, Veronica, 2022-07-20 |
| journal | EMBO Mol Med |
| pubMedIdentifier | 29531021 |
| title | Tranilast directly targets NLRP3 to treat inflammasome-driven diseases |
| volume | 10 |
| year | 2018 |
| (literatureReference) | [Reaction:9794816] Tranilast binds NLRP3 [Homo sapiens] [Summation:9794812] A tryptophan metabolite analog tranilast (N-[3′,4′-dimethoxy... |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Tranilast directly targets NLRP3 to treat inflammasome-driven diseases (9794809)
